# Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

> **NCT00568009** · — · TERMINATED · sponsor: **Solvay Pharmaceuticals** · enrollment: 300 (estimated)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** SLV320

## Key facts

- **NCT ID:** NCT00568009
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 300 (ESTIMATED)
- **Why stopped:** additional enrolment criteria made patients' recruitment not feasible anymore
- **Last updated:** 2008-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568009, "Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00568009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*